Rocket


News + Filings
Transactions
Holdings


All
13F
13D/G
Other

Schelling Chris Create: Alert

All | News | Filings
Date FiledTypeDescription
12/02/2022 SC 13D/A Schelling Chris reports a 16% stake in Acer Therapeutics Inc.
12/01/2022 4 Schelling Chris (President & CEO) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Bought 819,672 shares @ $1.22, valued at $1000k
01/19/2022 4 Schelling Chris (President & CEO) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 50,000 options to buy @ $2.21, valued at $110.5k
01/20/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
08/03/2020 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/28/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/05/2019 4 Schelling Chris (President and Chief Executive) has filed a Form 4 on Acer Therapeutics Inc.
Txns: Granted 72,500 options to buy @ $24.46, valued at $1.8M
10/06/2017 4 Form 4 - Statement of changes in beneficial ownership of securities:
09/29/2017 SC 13D Form SC 13D - General statement of acquisition of beneficial ownership:

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy